Diversified Healthcare Trust (NASDAQ:DHC) Shares Sold by Arrowstreet Capital Limited Partnership

Arrowstreet Capital Limited Partnership lowered its position in Diversified Healthcare Trust (NASDAQ:DHC) by 4.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,418,920 shares of the real estate investment trust’s stock after selling 64,202 shares during the period. Arrowstreet Capital Limited Partnership’s holdings in Diversified Healthcare Trust were worth $3,264,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Proficio Capital Partners LLC purchased a new position in shares of Diversified Healthcare Trust in the fourth quarter valued at $44,000. KLP Kapitalforvaltning AS purchased a new position in Diversified Healthcare Trust during the 4th quarter valued at about $76,000. Pictet Asset Management Holding SA raised its position in Diversified Healthcare Trust by 134.5% during the fourth quarter. Pictet Asset Management Holding SA now owns 34,147 shares of the real estate investment trust’s stock worth $79,000 after acquiring an additional 19,583 shares during the last quarter. Quantbot Technologies LP lifted its holdings in shares of Diversified Healthcare Trust by 64.4% in the fourth quarter. Quantbot Technologies LP now owns 34,175 shares of the real estate investment trust’s stock valued at $79,000 after purchasing an additional 13,388 shares in the last quarter. Finally, Intech Investment Management LLC grew its position in shares of Diversified Healthcare Trust by 132.4% in the fourth quarter. Intech Investment Management LLC now owns 103,558 shares of the real estate investment trust’s stock valued at $238,000 after purchasing an additional 59,006 shares during the last quarter. 75.98% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research analysts recently issued reports on DHC shares. StockNews.com upgraded Diversified Healthcare Trust from a “sell” rating to a “hold” rating in a research report on Tuesday, April 1st. B. Riley started coverage on Diversified Healthcare Trust in a research note on Thursday, April 3rd. They set a “buy” rating and a $4.50 price objective on the stock.

Diversified Healthcare Trust Stock Down 6.2 %

Shares of NASDAQ DHC opened at $2.12 on Wednesday. The firm’s 50 day moving average price is $2.55 and its 200 day moving average price is $2.73. The company has a debt-to-equity ratio of 1.44, a quick ratio of 11.57 and a current ratio of 11.57. The firm has a market cap of $511.42 million, a P/E ratio of -1.32 and a beta of 2.02. Diversified Healthcare Trust has a 1 year low of $2.01 and a 1 year high of $4.24.

Diversified Healthcare Trust (NASDAQ:DHC) last announced its quarterly earnings data on Tuesday, February 25th. The real estate investment trust reported $0.02 EPS for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.31. Diversified Healthcare Trust had a negative return on equity of 17.55% and a negative net margin of 26.09%. The business had revenue of $379.62 million during the quarter, compared to the consensus estimate of $370.97 million.

Diversified Healthcare Trust Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, February 20th. Investors of record on Monday, January 27th were issued a $0.01 dividend. The ex-dividend date of this dividend was Monday, January 27th. This represents a $0.04 dividend on an annualized basis and a yield of 1.89%. Diversified Healthcare Trust’s payout ratio is -2.60%.

About Diversified Healthcare Trust

Diversified Healthcare Trust is a real estate investment trust, which engages in the ownership of senior living communities, medical office buildings, and wellness centers. It operates through the following segments: Office Portfolio, Senior Housing Operating Portfolio (SHOP), and Non-Segment. The Office Portfolio segment consists of medical office properties leased to medical providers and other medical related businesses, as well as life science properties leased to biotech laboratories and other similar tenants.